MPX - Melting Point Extracts

In May 2026, MPX - Melting Point Extracts leaned even further into Concentrates at 87.10% share, yet that anchor category fell 52.32% year over year and 15.30% month over month, while the brand’s overall sales declined 61.05% year over year and average price rose 9.74%. Flower held 8.18% share with a 30.20% year-over-year decline but a 3.76% month-over-month increase, contrasting with Pre-Roll at 2.60% share dropping 76.09% year over year and 60.56% month over month, and Vapor Pens at 2.12% share sliding 95.88% year over year and 37.09% month over month; with Concentrates average price at $35.22 against brand-wide $36.11, the mix is tilting toward a category experiencing sharper unit contraction than pricing can offset. The pattern implies a concentration risk: heavy reliance on Concentrates is amplifying downturns, while a modest month-over-month uptick in Flower suggests a small hedge that is not yet large enough to counter broad category retrenchment.

The category shifts point to a positioning anchored in Concentrates with a niche foothold in Flower, but the 15.30% month-over-month drop in Concentrates alongside a 3.76% month-over-month gain in Flower indicates latent elasticity that could rebalance revenue if Flower’s 8.18% share expands. With Vapor Pens and Pre-Roll contracting 37.09% and 60.56% month over month respectively from already low 2.12% and 2.60% shares, exiting or deprioritizing those segments would have limited near-term revenue impact, whereas stabilizing Concentrates—despite a 52.32% year-over-year decline—and selectively growing Flower could reduce volatility; ranked 9 in Concentrates in New Jersey, the brand sits mid-pack, implying that incremental share capture in that channel may be more attainable than rebuilding in shrinking minor categories.